Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Degenerates is headed down into the murkiest trenches, the depths where creatures are born without eyes. What’s most striking ...
DiFusion Therapeutic Biomaterials today announced that it will use the North American Spine Society 2026 Annual Meeting in San Antonio, October 14-17, to define an emerging orthopedic category: ...
AptarGroup stays on hold: revenue rises but profitability lags and valuation looks rich vs. peers. Click for more on ATR ...
The veteran manufacturing technology leader is using lighthouse projects, enterprise grade intelligence and product IT to ...
The seven-time Super Bowl champion has found a new way to stand out in the FOX booth, giving NFL fans some memorable names ...
The next competitive advantage in our industry won't belong to whoever has the most data or the smartest AI. It’ll go to ...
Simplify Health Care ETF shifts to Hold as healthcare’s discount fades but valuations stay reasonable (16–18x forward P/E).
The Juzear Light Shuttle combines tribrid drivers, strong sub-bass, clear mids and smooth treble in a competitive sub-$200 ...
When I put tasks on my calendar, I feel like I've made some progress.Colored squares line up. From morning to evening, it's quite an impressive sight.However, those squares haven't delivered anything ...
Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have ...
Fujairah’s open-sky policy has enabled a specialised MRO niche centred on accessibility, low congestion and business aviation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results